{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:37:45Z","timestamp":1794209865302,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmgm.2026.109327","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:17:00Z","timestamp":1771258620000},"page":"109327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fragment-based drug design coupled with AI\/ML prediction enables identification of novel PARP-1 inhibitors against triple-negative breast cancer"],"prefix":"10.1016","volume":"144","author":[{"given":"Aayushi","family":"Bhatnagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-0137","authenticated-orcid":false,"given":"Vipin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109327_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2026.109327_bib2","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jmgm.2026.109327_bib3","volume":"vol. 14","author":"Visan","year":"2024"},{"key":"10.1016\/j.jmgm.2026.109327_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2026.109327_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106324","article-title":"CADD, AI and ML in drug discovery: a comprehensive review","volume":"181","author":"Vemula","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jmgm.2026.109327_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2016.07.003","article-title":"The ways and means of fragment-based drug design","volume":"167","author":"Doak","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jmgm.2026.109327_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115301","article-title":"Recent trends in fragment-based anticancer drug design strategies against different targets: a mini-review","volume":"206","author":"Moinul","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109327_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49892-9","article-title":"In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot","volume":"15","author":"An","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2026.109327_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2301758","article-title":"Computational fragment-based drug design of potential Glo-I inhibitors","volume":"39","author":"Bibars","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109327_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1574892816666210728123758","article-title":"Artificial intelligence and cancer drug development, recent pat","volume":"17","author":"Yang","year":"2021","journal-title":"Anticancer Drug Discov"},{"key":"10.1016\/j.jmgm.2026.109327_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7717\/peerj-cs.1903","article-title":"Optimized models and deep learning methods for drug response prediction in cancer treatments: a review","volume":"10","author":"Hajim","year":"2024","journal-title":"PeerJ Comput. Sci."},{"key":"10.1016\/j.jmgm.2026.109327_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115401","article-title":"DeepCancerMap: a versatile deep learning platform for target- and cell-based anticancer drug discovery","volume":"255","author":"Wu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109327_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500143","article-title":"Machine learning-driven QSAR modeling of anti-cancer activity from a rationally designed synthetic flavone Library","author":"Vijara","year":"2025","journal-title":"ChemMedChem n\/a"},{"key":"10.1016\/j.jmgm.2026.109327_bib14","first-page":"362","article-title":"Revolutionizing cancer research and drug discovery: the role of artificial intelligence and machine learning","volume":"20","author":"Paliwal","year":"2024","journal-title":"Curr. Cancer Ther. Rev."},{"key":"10.1016\/j.jmgm.2026.109327_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115301","article-title":"Recent trends in fragment-based anticancer drug design strategies against different targets: a mini-review","volume":"206","author":"Moinul","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109327_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2026.109327_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109327_bib18","article-title":"Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms","author":"Jain","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.jmgm.2026.109327_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194571","article-title":"BRCA mutation status in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: a pivotal role for treatment decision-making","volume":"14","author":"Pavese","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmgm.2026.109327_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.703802","article-title":"Harnessing DNA repair defects to augment immune-based therapies in triple-negative breast cancer","volume":"11","author":"Clark","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109327_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.769280","article-title":"Emerging role of PARP inhibitors in metastatic triple negative breast cancer. Current scenario and future perspectives","volume":"11","author":"Barchiesi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109327_bib22","first-page":"84","article-title":"Parp1Pred: a web server for screening the bioactivity of inhibitors against dna repair enzyme Parp-1","volume":"22","author":"Lerksuthirat","year":"2023","journal-title":"EXCLI J"},{"key":"10.1016\/j.jmgm.2026.109327_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","article-title":"PARP-1 activation requires local unfolding of an autoinhibitory domain","volume":"60","author":"Dawicki-McKenna","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmgm.2026.109327_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines9111512","article-title":"Role of parp in tnbc: mechanism of inhibition, clinical applications, and resistance","volume":"9","author":"Singh","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmgm.2026.109327_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2026.109327_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-022-05060-8","article-title":"Identification of behenic acid as medicinal food for the diabetes mellitus: structure-based computational approach and molecular dynamics simulation studies","volume":"28","author":"Nath","year":"2022","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jmgm.2026.109327_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10822-009-9281-4","article-title":"Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using glide","volume":"23","author":"Kawatkar","year":"2009","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2026.109327_bib28","series-title":"Management of RET-positive Non-small Cell Lung","author":"Ramesh","year":"2022"},{"key":"10.1016\/j.jmgm.2026.109327_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28186678","article-title":"Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents","volume":"28","author":"Lotfi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109327_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11030-024-10837-5","article-title":"Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches","volume":"29","author":"Lanka","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2026.109327_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s10822-025-00727-9","article-title":"Identification of antidiabetic leads using in-silico screening, molecular dynamics simulation, and biological evaluation using cell viability, anti-adipogenesis, glucose uptake, and peroxisome proliferator activated receptor-\u03b3 in-vitro assay","volume":"40","author":"Nath","year":"2026","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2026.109327_bib32","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109327_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2020.129006","article-title":"Computational identification of potential dipeptidyl peptidase (DPP)-IV inhibitors: structure based virtual screening, molecular dynamics simulation and knowledge based SAR studies","volume":"1224","author":"Nath","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2026.109327_bib34","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1080\/07391102.2023.2214223","article-title":"Discovery of novel PARP-1 inhibitors using tandem in silico studies: integrated docking, e-pharmacophore, deep learning based de novo and molecular dynamics simulation approach","volume":"42","author":"Bhatnagar","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109327_bib35","first-page":"1813","article-title":"The many roles of computation in drug discovery","volume":"303","author":"Jorgensen","year":"2004","journal-title":"Science (1979)"},{"key":"10.1016\/j.jmgm.2026.109327_bib37","first-page":"341","volume":"330","author":"Shaw","year":"2010","journal-title":"Atomic-Level Characterization"},{"key":"10.1016\/j.jmgm.2026.109327_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00050","article-title":"Molecular mechanism of selective binding of NMS-P118 to PARP-1 and PARP-2: a computational perspective","volume":"7","author":"Wang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmgm.2026.109327_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109327_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278491","article-title":"Feature selection in wind speed forecasting systems based on meta-heuristic optimization","volume":"18","author":"El-Kenawy","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2026.109327_bib41","first-page":"695","article-title":"Early detection of potato disease using an enhanced convolutional neural network-long short-term memory deep learning model","volume":"68","author":"Alzakari","year":"2025","journal-title":"Potato Res."},{"key":"10.1016\/j.jmgm.2026.109327_bib42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s11540-024-09717-0","article-title":"Forecasting production of potato for a sustainable future: global market analysis","volume":"67","author":"Mishra","year":"2024","journal-title":"Potato Res."},{"key":"10.1016\/j.jmgm.2026.109327_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/technologies12070095","article-title":"Integrating artificial intelligence to biomedical science: new applications for innovative stem cell research and drug development","volume":"12","author":"Kim","year":"2024","journal-title":"Technologies"},{"key":"10.1016\/j.jmgm.2026.109327_bib44","article-title":"Active disease-related compound identification based on capsule network","volume":"23","author":"Yang","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.jmgm.2026.109327_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-025-11511-2","article-title":"scAMZI: attention-based deep autoencoder with zero-inflated layer for clustering scRNA-seq data","volume":"26","author":"Yuan","year":"2025","journal-title":"BMC Genom."},{"key":"10.1016\/j.jmgm.2026.109327_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/0115748936330499240909082529","article-title":"CLPr_in_ML: cleft lip and palate reconstructed features with machine learning","volume":"20","author":"Chen","year":"2025","journal-title":"Curr. Bioinform"},{"key":"10.1016\/j.jmgm.2026.109327_bib47","article-title":"Oral_voting_transfer: classification of oral microorganisms' function proteins with voting transfer model","volume":"14","author":"Bao","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmgm.2026.109327_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00180","article-title":"Application of fragment-based drug discovery to versatile targets","volume":"7","author":"Li","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmgm.2026.109327_bib49","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/1878-0261.13277","article-title":"Fragment-based drug discovery\u2014the importance of high-quality molecule libraries","volume":"16","author":"Bon","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jmgm.2026.109327_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108197","article-title":"Fragment-based drug discovery: small fragments, big impact \u2212 success stories of approved oncology therapeutics","volume":"156","author":"Khedkar","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2026.109327_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109327_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.769280","article-title":"Emerging role of PARP inhibitors in metastatic triple negative breast cancer. Current scenario and future perspectives","volume":"11","author":"Barchiesi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109327_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/app12115554","article-title":"New achievements for the treatment of triple-negative breast cancer","volume":"12","author":"Catalano","year":"2022","journal-title":"Appl. Sci."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:14:25Z","timestamp":1772525665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"alternative-id":["S1093326326000537"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109327","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fragment-based drug design coupled with AI\/ML prediction enables identification of novel PARP-1 inhibitors against triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109327"}}